share_log

HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $9 Price Target

Benzinga ·  Apr 30 06:31

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aquestive Therapeutics (NASDAQ:AQST) with a Buy and maintains $9 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment